- Home
- WULF vs NVCR Comparison
WULF vs NVCR Comparison
Compare WULF & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WULF | NVCR |
|---|---|---|
| Founded | 1952 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 2.0B |
| IPO Year | 1999 | 2015 |
Fundamental Metrics
Financial Performance| Metric | WULF | NVCR |
|---|---|---|
| Price | $28.97 | $14.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $20.86 | ★ $28.08 |
| AVG Volume (30 Days) | ★ 24.9M | 1.4M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | N/A | ★ N/A |
| Revenue | $168,455,000.00 | ★ $655,353,000.00 |
| Revenue This Year | $126.80 | $7.72 |
| Revenue Next Year | $162.52 | $6.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.28 | 8.28 |
| 52 Week Low | $4.23 | $9.82 |
| 52 Week High | $29.67 | $18.92 |
Technical Indicators
Market Signals| Indicator | WULF | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 64.01 | 36.95 |
| Support Level | $10.97 | $12.66 |
| Resistance Level | N/A | $15.46 |
| Average True Range (ATR) | 1.94 | 1.04 |
| MACD | 0.20 | -0.27 |
| Stochastic Oscillator | 89.52 | 8.87 |
Price Performance
Historical ComparisonAbout WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.